1. Approving vaccines
1.1. Need manufacturer
1.2. Risks of costs
1.3. Risks of time
1.4. Vaccines are delicate
2. Providing vaccine
2.1. Older adults
2.1.1. In doses
2.1.2. With an adjuvant
2.2. Medical professionals
2.2.1. High risk of exposure
2.2.2. Need to give vaccine
3. Vaccine Production
3.1. Quickly produced
3.1.1. Usage of the virus' genome
3.2. Long-lasting effects
3.2.1. Taking the virus’ genetic snapshot and put it into a different virus for transport
4. Steps on testing a vaccine
4.1. Step 1: Show safety in preclinical studies
4.1.1. In vitro (only cells)
4.1.2. In vivo (on animals)
4.2. Step 2:Trials in humans
4.2.1. Phase 1
4.2.1.1. About a dozen of closely monitored participants
4.2.2. Phase 2
4.2.2.1. Enrollment of hundreds of patients to expand the safety assessment
4.2.3. Phase 3
4.2.3.1. Thousands of people are enrolled, just that some of them can receive placebos
5. Protection
5.1. Do NOT
5.1.1. Close contact
5.1.2. Touch eyes, mouth or nose
5.2. DO
5.2.1. Wash hands
5.2.2. Alcohol-based sanitizer
5.2.3. Stay home
5.2.4. Use face mask
5.2.5. Disinfect areas
5.2.6. Use tissue
6. Types of vaccines
6.1. Attenuated
6.2. Inactivated
6.3. Toxoid
6.4. Subunit
6.5. Conjugate
7. Immune system
7.1. Threat
7.1.1. Macrophages
7.1.2. B-lymphocytes
7.1.3. T-lymphocytes
7.2. Vaccine: shortcut
8. Create a vaccine
8.1. Techniques
8.1.1. Killed virus
8.1.2. Weakened virus
8.1.3. Reconstruct DNA/RNA
9. Approval Requirements
9.1. Safety
9.1.1. The vaccine won't kill the patient
9.2. Effectiveness
9.2.1. It depends on the virus, but usually a ratio of 50% cured is the standard